Combined effects of reproductive and hormone factors and obesity on the prevalence of knee osteoarthritis and knee pain among middle-aged or older Chinese women: a cross-sectional study

生殖和激素因素及肥胖对中国中老年女性膝骨关节炎和膝关节疼痛患病率的综合影响:一项横断面研究

阅读:1

Abstract

BACKGROUND: Knee osteoarthritis (KOA) is one form of degenerative arthritis that results from the breakdown of cartilage and underlying bone. The prevalence of KOA is considerably higher in women than in men; however, the reason for this difference has not been thoroughly elucidated to date. The aim of the present study was to estimate the effects of reproductive and hormone factors and obesity on KOA prevalence among Chinese women. METHODS: The cross-sectional study included 7510 women with a mean age of 62.6 ± 8.6 years. Knee pain was defined as pain or aching stiffness on most days for at least 1 month during the past 12 months or persistent pain or aching stiffness within the past week. Clinical KOA was diagnosed based on both pain complaints and a Kellgren-Lawrence grade ≥ 2 X-ray radiograph of at least one knee. RESULTS: Oral contraceptives use (OR 1.18, 1.05-1.34), ≥3 pregnancies (1.38, 1.20-1.60), and postmenopausal hormone replacement therapy (HT) (1.59, 1.23-2.06) were positively associated with knee pain, while oral contraceptives use (1.28, 1.04-1.57), and HT (1.79, 1.21-2.65) were positively associated with clinical KOA. Obesity and oral contraceptives use showed additive and multiplicative effects on knee pain. The OR for knee pain among women with a BMI ≥24 kg/m(2) and oral contraceptives use was 2.00 (1.68-2.38) compared with women with a BMI < 24 kg/m(2) and no oral contraceptives use. CONCLUSIONS: A high number of pregnancies, oral contraceptives use, and HT are independent risk factors for KOA, and the effects of reproductive and hormone factors on KOA may be increased by obesity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。